The importance of cell surfaces in the self-assembly of proteins is widely accepted. One biologically significant event is the assembly of amyloidogenic proteins into aggregates, which leads to neurodegenerative disorders like Alzheimer's and Parkinson's. The interaction of amyloidogenic proteins with cellular membranes appears to dramatically facilitate the aggregation process. Recent findings indicate that, in the presence of surfaces, aggregation occurs at physiologically low concentrations, suggesting interaction with surfaces plays a critical role in the disease-prone aggregation process. However, the molecular mechanisms behind onsurface aggregation remain unclear. Here we provide a theoretical model that offers a molecular explanation. According to this model, monomers transiently immobilized to surfaces increase the local monomer protein concentration and thus work as nuclei to dramatically accelerate the entire aggregation process. This theory was verified by experimental studies, using mica surfaces, to examine the aggregation kinetics of amyloidogenic-synuclein protein (α-Syn) and non-amyloidogenic cytosine deaminase APOBEC3G (A3G).
Main text
The assembly of proteins into aggregates of various type is a general phenomenon found frequently in both natural and industrial processes (1, 2) . Different types of protein aggregates are commonly observed. For example, proteins can self-assemble into filamentous aggregates;
the actin filament is one of the numerous examples of this process. Another, and the most known example, is the formation of aggregates by amyloidogenic proteins. According to the current views, the formation of amyloidogenic aggregates is a hallmark in the development of numerous disorders, including neurodegenerative diseases such as Alzheimer's disease (3) . Although the self-assembly of protein aggregates can take place in a solution, the importance of membrane surfaces in such processes is also acknowledged (e.g., (4) (5) (6) ).
In general, the aggregation process is accelerated in the presence of membranes (e.g., (7) and references therein). With respect to Alzheimer's disease, great interest has been given to the role of membranes in disease pathogenesis and in facilitating the assembly of amyloid fibrils (e.g., reviews (6, (8) (9) (10) (11) (12) ). Importantly, the inclusion of cholesterol and gangliosides into membranes changes the structure and stability of amyloid agregates; these changes appear to contribute to the neurotoxic effect of aggregates (10), (11) . However, a molecular mechanism explaining the catalysis of membrane surfaces toward protein aggregation remains poorly understood.
Recent studies have shown that, similar to membranes, surfaces such as glass (13) , mica (14, 15) , and zeolites (16) also accelerate the aggregation process for various amyloidogenic proteins. Importantly, amyloid aggregates, primarily fibrils, have been imaged using electron microscopy (16) and AFM (14, 15) . As such, the use of solid surfaces has made it possible to partially visualize the molecular mechanism behind the surface-acceleration effect. According to the model proposed in (14, 15) , the accelerated aggregation is due to the fast, two-dimensional diffusion of amyloid peptide molecules at the surface-liquid interface.
AFM has been used to directly observe the accelerated aggregation of amyloid peptides and the alpha-synuclein (α-Syn) protein on mica surfaces. Results demonstrated that the assembly of proteins into aggregates took place at a low protein concentrations, while no aggregation was detected in bulk solution (17) . Importantly, time-lapse AFM experiments in liquid did not reveal fast mobility of molecules at the mica-liquid interface (17) . These data were also in line with observations performed using time-lapse high-speed AFM (18, 19) . These results suggest an alternative mechanism of accelerated aggregation on the surface that does not include surface diffusion. Such a mechanism is proposed in the current work.
Here a novel theoretical model is provided to explain the molecular mechanism of the surface-mediated catalysis behind the protein aggregation process. According to this model, aggregation starts with protein monomers transiently attaching to the surface due to molecular interactions. This process increases the local concentration of proteins, which in turn increases the probability of oligomerization reactions to occur on the surface. Based on this model, aggregation occurs by the assembly of oligomers on these transiently bound monomers. This theoretical prediction was experimentally tested using two proteins that follow different aggregation pathways. One such protein, α-Syn, is a typical amyloidogenic protein capable of assembling into aggregates of various morphologies, including fibrils. The other protein, cytosine deaminase APOBEC3G (A3G), assembles into oligomers of various sizes depending on the protein concentration (e.g., (20) and references therein).
To explain the complex processes of surface-assisted protein aggregation, a new theoretical model was further developed. The main assumptions for this theoretical model are as follows:
1) Due to intrinsic interactions with surfaces, protein monomers very quickly bind to the surface and establish an effective equilibrium between surface-bound and free monomers in solution. The equilibrium coverage is given by the parameter 0 < θ < 1, which describes what fraction of the surface is covered by protein monomers.
2) The effective concentration of monomers near the surface increases in comparison to concentration in bulk solution, and this accelerates the rates of oligomerization.
To examine these arguments quantitatively, C(t) can be defined as the time-dependent concentration of protein monomers in solution. At t = 0, C(t) = C 0 . This represents the initial concentration of proteins in solution. Assuming that the surface area is equal to L 2 , and the molecular volume of one protein monomer is v 0~d 3 , the maximum possible number of monomers on the surface can be estimated as follows:
The number of adsorbed proteins can be given by N 1 , where
For a solution in the absence of a surface, the reaction rate for the formation of dimers as a first step of aggregation can be calculated as follows, where k is the bulk rate constant:
However, in the presence of the surface, the following equation can applied:
In the equation above, k s represents the reaction rate for the formation of dimers on the surface, and C 1 represents the concentration of the protein monomers in the volume around the surface.
It can be estimated using equations 1 and 2, with N A being Avogadro's number, as follows:
Now the acceleration factor can be evaluated in the reaction rate due to the presence of the surface at earlier times.
To estimate this factor using more or less realistic parameters, very low coverage is assumed, with θ = 0.001 (0.1%), C 0 = 100 nM, v 0 ~ 100 nm 3 , and ! ! ! = 0.01. This is because the reaction rate on the surface is expected to be smaller than in bulk solution due to steric constraints and possible conformational changes. Next, γ ~ 1.6*10 3 can be obtained, which represents a markedly accelerated aggregation process due to the presence of the surface.
These calculations show that the aggregation in bulk solution is relatively slow; the dominating chemical process in the system is the formation of oligomers on the surface. This can be described by the following quasi-chemical reaction, where C represents bulk protein monomers; C 1 represents surface-bound protein monomers; C 2 represents surface-bound dimers:
Next, C 2 (t) can be given as the time-dependent concentration of dimers, with C 2 (t=0) =0
and the rate constant k s . As such, the chemical kinetic equations for this system can be written as follows:
These equations can be easily solved to produce the following:
If the reaction rate on the surface is assumed to be relatively slow and/or the time relatively short, then equation 11 can be expanded to linear terms of time, yielding the following:
From this expression, the ratio of dimers-to-monomers on the surface as a function of time can be given by the following:
This result predicts that the ratio will grow linearly with time, and it will be proportional to the original concentration of the protein monomers in bulk solution.
To experimentally test these theoretical predictions, an approach developed by us recently (17) was applied, as shown schematically in Figure 1 . A mica sheet was placed in a test tube ( Fig. 1A) containing the protein solution and incubated at room temperature for finite time;
afterwards, to directly count the number of aggregates appearing on the surface, the mica was removed, rinsed with water, dried, and imaged using AFM (Fig. 1B) . Such experiments were performed at different incubation times. As a control, aliquots were taken from the same protein solution, but no mica strip was added (Fig. 1C) . The AFM image for the control is shown in Fig.   1D . Figure Similar to the data obtained for 2 nM α-Syn, the ratio of the number of oligomers-tomonomers increases gradually over time. The early aggregation kinetic graphs were fitted with the linear plot (Fig. S6A) , and the slope for 10 nM of α-Syn turned out to be larger than for 2 nM α-Syn, which is in line with the theoretical predictions. Meanwhile, no time-dependent aggregation was observed for 10 nM α-Syn in the bulk solution (Fig. S6B ), similar to control experiments for 2 nM of α-Syn.
To further test theoretical predictions, experiments were performed with the A3G protein, which has a strong propensity toward oligomerization depending on its concentration in solution (20) . This feature is considered an additional mechanism for the antiviral activity of A3G. Figure S8 provides a quantitative analysis of the aggregation data and demonstrates that the oligomer-to-monomer ratio increases over time. Figure 3C shows the initial process of the aggregation kinetics (between 0 and 2 hours) fitted with a linear plot. On the other hand, aggregation of A3G in solution is not timedependent, showing no change in the oligomer-to-monomer ratio over time (Fig. 3D) . Table S1 in the supporting information section assembles data characterizing the kinetics for the onsurface aggregation of both α-Syn and A3G proteins.
Overall, the data obtained support the theoretical model for which the key factor defining the on-surface aggregation process is transient binding of monomers that play the role as nuclei in the assembly of aggregates. Importantly, the model works not only for α-Syn, a typical member of amyloidogenic proteins capable of assembly of into fibrils, as supported by numerous studies including ours (21) (22) (23) , but also for A3G enzyme, for which the stoichiometry of aggregates is defined by the concentration of monomers (20) . Notably, unlike the amyloid aggregates that dramatically change the physiological function of monomers ((24) and references therein), the assembly of A3G into oligomers contributes to its anti-HIV activity of A3G ( (25) and references therein).
According top the theory (Eq. 2), the kinetics of on-surface aggregation depends on the affinity of the protein to the surface. The elevated propensity of A3G compared with α-Syn to form aggregates on surface points to its high affinity for the mica surface; this feature is in line with the high affinity of this protein to cellular the membrane and other intracellular particles (26, 27) .
Although the experimental results support the theoretical prediction regarding the linear dependence for the initial aggregation process on time (Eq. 13), the dependence on the concentration is not fully in line with theoretical predictions. According to Table S1 , the fivefold increase in the α-Syn concentration does not change the aggregation rate five-fold; only a two-fold increase is observed. However, this result is not surprising considering the theory does not include factors such as changes in the protein conformation upon the interaction with surfaces. Moreover, the formation of oligomers larger than dimers also can influence aggregation kinetics. Indeed, our computational simulation previously showed that amyloid beta peptide (Aβ) (14-23) undergoes a conformational change that facilitates the assembly of dimers (17) . Based on our recent studies for the aggregation of α-Syn aggregation on membrane surfaces (28) , it is reasonable to assume that α-Syn also undergoes a conformational change at the mica-liquid interface. Meanwhile, comparison of α-Syn aggregation on membrane bilayers of different compositions induced different conformational changes and resulted in only several-fold changes to the aggregation propensities of membranes (28) . This value is considerably less than the overall aggregation catalysis of membranes and mica, which is in the range of several orders of magnitude (17) ; such an acceleration is in line with the current theoretical predictions. However, understanding the effect of the membrane composition on the entire on-surface aggregation process can explain the role of membrane surfaces in the assembly of amyloid aggregates (28) 
